Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Saltsjöbaden

2 clinical trials in Saltsjöbaden, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Saltsjöbaden at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 trials in Saltsjöbaden

Open in trial search

Respiratory syncytial virus infection

Recruiting
Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:Karolinska Institutet

Diabetic foot

Recruiting
Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
  • Sponsor:University Of Gothenburg

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Saltsjöbaden

What the registry says about research in the country

01 Saltsjöbaden
Diseases [C] - Virus Diseases [C02]
In Saltsjöbaden, clinical research in this area focuses on RSV infection and the immune response to prevention-focused interventions. These studies are looking at how well a new approach can support protection against respiratory viral illness in older adults. RSV infection Respiratory tract diseases Evaluating immune protection against viral infection The work is centered on understanding whether the intervention can strengthen the body’s defense against RSV and help reduce the impact of this common respiratory virus.
Diseases [C] - Respiratory Tract Diseases [C08]
This research field covers trials aimed at preventing or reducing illness related to respiratory tract diseases, with a strong focus on RSV infection. The main goal is to assess how effective a vaccine-based strategy may be in older adults. Respiratory tract disease prevention RSV antibody response Testing a new preventive therapy These studies help clarify whether the intervention can improve protection in populations more vulnerable to severe respiratory infections.
Diseases [C] - Bacterial Infections and Mycoses [C01]
Clinical trials in this therapeutic area are examining treatment options for Diabetic Foot Ulcer, a wound complication where infection control and healing are major concerns. The research is focused on finding better local antimicrobial care to support complete wound closure. Diabetic Foot Ulcer Bacterial infection management Improving wound healing outcomes In Sweden, this line of research is comparing approaches that may help clinicians choose more effective treatments for difficult-to-heal ulcers.
Diabetic Foot Ulcer
The trial activity around Diabetic Foot Ulcer is aimed at evaluating how well local antimicrobial agents help wounds heal. It is a practical, patient-centered area of research focused on treatment effectiveness and recovery. Local antimicrobial treatment Time to healing Wound care and infection control These studies are intended to improve everyday care for people living with chronic foot ulcers linked to diabetes.
RSV infection
Research on RSV infection is centered on prevention and immune response in older adults, especially those at higher risk of severe disease. The trials are assessing whether a new protective strategy can generate helpful neutralizing antibodies. Older adult respiratory health Immune response to RSV Preventive vaccine research This work supports better understanding of how to reduce the burden of RSV in aging populations.
Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.